These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The state of periprocedural antiplatelet therapy after recent trials. Desai NR; Bhatt DL JACC Cardiovasc Interv; 2010 Jun; 3(6):571-83. PubMed ID: 20630450 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes. Jennings LK; Saucedo JF Curr Opin Cardiol; 2008 Jul; 23(4):302-8. PubMed ID: 18520712 [TBL] [Abstract][Full Text] [Related]
11. Tackling the gap in platelet inhibition with oral antiplatelet agents in high-risk patients undergoing percutaneous coronary intervention. Capranzano P; Angiolillo DJ Expert Rev Cardiovasc Ther; 2021 Jun; 19(6):519-535. PubMed ID: 33881367 [No Abstract] [Full Text] [Related]
12. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future. De Luca G; Savonitto S; van't Hof AW; Suryapranata H Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890 [TBL] [Abstract][Full Text] [Related]
13. Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. Saucedo JF J Thromb Thrombolysis; 2010 Aug; 30(2):200-9. PubMed ID: 20111983 [TBL] [Abstract][Full Text] [Related]
14. De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Guo C; Li M; Lv YH; Zhang MB; Wang ZL Platelets; 2020; 31(1):15-25. PubMed ID: 30759033 [TBL] [Abstract][Full Text] [Related]
15. The problem of persistent platelet activation in acute coronary syndromes and following percutaneous coronary intervention. Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I17-20. PubMed ID: 18481817 [TBL] [Abstract][Full Text] [Related]
16. Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: focus on adenosine diphosphate receptor inhibitors. Ogawa H; Hokimoto S; Kaikita K; Yamamoto K; Chitose T; Ono T; Tsujita K J Cardiol; 2011 Jul; 58(1):6-17. PubMed ID: 21530174 [TBL] [Abstract][Full Text] [Related]